CSMG Technologies Subsidiary LTC Testing New Tissue Welding/Bonding Equipment
Corpus Christi, TX, December 8, 2005 -- CSMG Technologies, Inc., (OTC Bulletin Board: CTUM) announced today its subsidiary Live Tissue Connect, Inc. (LTC) has begun development and testing of a new set of live biological tissue welding/bonding equipment.
The equipment is designed specifically for vessel and duct sealing procedures using an automatic mode setting from the company's patented platform welding/bonding technology. The automated unit testing on vessels and ducts is expected to begin in mid-January and be completed in mid-March 2006. Tests will include vessels ranging from 3 to 14 mm diameter in size.
Following completion of the unit, LTC will complete development and testing of new equipment specifically for intestine reconnection and repair with end-to-end and end-to-side procedure techniques using an automated mode.
Don Robbins, CEO of CSMG Technologies, said, "During demonstrations, we have shown the superior capability of the tissue welding technology for repair and reconnection of tissue and hollow organs. Our technology is smokeless, generates little heat migration in the tissue, causes no necrosis and is without the use of staples, sutures, glues or sealant. Procedures are almost bloodless and completed in less time. We have successfully completed more than 3,000 clinical trials in Ukraine that demonstrate our technology to be universal in its ability to repair soft biological tissue. These surgeries have included the bonding and reconnecting of incised or separated human soft tissues for lung, neuro-surgery, nasal septum, intestine, stomach, skin, gall bladder, liver, spleen, blood vessels, nerves, alba linea, uterus, bladder, gynecology, fallopian tube, ovary and testicles and dura-matter. Little or no scarring resulted, and the normal function of the body organ or tissue was restored."
Robbins continued, "We will now focus on specific surgical equipment for surgeons. Surgical specialists and specialty procedures require specialty equipment. Our technology for these surgeons will be designed with an automatic mode requiring little or no additional adjustments. This approach meets those specialty needs and allows LTC the opportunity to license detailed procedures to companies that specialize in each procedure market."
About CTUM's Tissue Bonding Technology CTUM's patented tissue welding/bonding device bonds through radiofrequency fusion and reconnects living soft biological tissue (organs) without the use of foreign matter or conventional wound-closing devices such as sutures, staples, sealant or glues. The technology leaves little or no scar visible to the naked eye after a few months. Unlike other tissue coagulation methods that tend to destroy tissue by charring, searing and necrosis, the CTUM patented technology bonds and reconnects incised tissue and avoids this by using a patented low-heat delivery method aimed at restoration of the normal functions of the live organs and tissue. U.S. and Australia patents have been issued with other U.S. and foreign patents pending.
In Ukraine, more than 3,000 successful human surgeries in clinical trials have been completed on various organs using a number of types of procedures. Surgeons at four Ukraine hospitals and clinics are using the tissue bonding technology in clinical trials and are performing open and laparoscopic surgical procedures.
CTUM owns the technology and exclusive world rights to the medical device through Live Tissue Connect, Inc., a subsidiary corporation formed for the development and exploitation of the platform technology. The technology, owned by CTUM, was invented and developed at the internationally renowned E.O. Paton Institute of Electric Welding, National Academy of Sciences of Ukraine at Kiev, Ukraine, headed by Professor B.E. Paton.
CTUM maintains offices in Corpus Christi, Texas, Washington D.C., Atlanta, Ga., and Kiev, Ukraine.
Additional information about CSMG can be found at http://www.ctum.com or e-mail publicrelations*ctum.com. An online investor kit containing CSMG press releases, SEC filings, current Level II price quotes, interactive Java, stock charts and other useful information for investors can be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com .
Investors may contact Don Robbins or K. Bruce Jones, CSMG, at (361) 887-7546, e-mail: publicrelations*ctum.com, or Frank Hawkins or Julie Marshall, Hawk Associates, at (305) 451-1888, e-mail: info*hawkassociates.com.
Safe-Harbor Statement: Under the Private Securities Litigation Reform Act of 1995. This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward- looking statements as a result of various factors.
Posts: 1335 | Registered: Oct 2003
| IP: Logged |
posted
It sounds good, but it must be approved by the FDA, and or American Medical Association, so don't get your hopes up right away. This will take time, and patients on the part of the investor. I would not recommend running out and buying a half a million shares tomorrow.
Posts: 280 | From: w.sacto.ca. u.s.a. | Registered: Feb 2004
| IP: Logged |
posted
CTUM do also have subsidiary in gas and others technologies. CSMG Technologies subsidiary Live Tissue Connect is only one part of this company. At .04 cents, this stock is very cheap and undervalued. I am expecting some move in next days( chart look good). I know how to choose and pick up winner stock. My previous post concern CNCN, CYBL and SYCI (see it somewhere here.) I do feel and know this is a big winner. Up to you to believe me or not. Anyway, if you do your own DD, you will find alot of info very interesting to know about CSMG Technologies products, insiders buyback. At this point it is just a matter of time before CTUM goes upwward. I learned to be patience with stock I picked because I am a swingtrader. I don't like popular stock. I am alway looking for underdog stock with big potentiel and from time to time I tell people here.
Posts: 1335 | Registered: Oct 2003
| IP: Logged |
posted
I base what I belive on what I read.Read last q10,carefully,there are some problems. This could go lower.
Posts: 280 | From: w.sacto.ca. u.s.a. | Registered: Feb 2004
| IP: Logged |
posted
insider buying here, so, it can't be too bad. gotta read the 10q yet, but I am interested. after a little further dd, i may look to pick some up for myself tommorrow. here's the s4: FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2008 Estimated average burden hours per response 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person*JONES K BRUCE
-------------------------------------------------------------------------------- (Last) (First) (Middle) 26 GANT QUARTERS TERRACE
-------------------------------------------------------------------------------- (Street)MARIETTA GA 30068
-------------------------------------------------------------------------------- (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol CONSORTIUM SERVICE MANAGEMENT GROUP INC [CTUM] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)X Director 10% Owner X Officer (give title below) Other (specify below) CFO
3. Date of Earliest Transaction (Month/Day/Year) 12/05/2005 4. If Amendment, Date of Original Filed (Month/Day/Year) 6. Individual or Joint/Group Filing (Check Applicable Line)X Form filed by One Reporting Person Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 12/05/2005 12/05/2005 P 30,000 A $ 0.044 489,433 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: /s/ K. Bruce Jones 12/06/2005 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
posted
Slim I respect your point of view and I like the way your thing (your seem very intelligent) but May I tell you that I read Q10 worst than that and stock went up. We are in penny stock world after all. Otherwise how to do explain some 1000% up on Pink sheet stock without any asset, income, etc? In any Q10 you will find almost the same statement warning investor about future income, possility of dilution, etc. (THAT FOR ME IT IS NOT NEW ON ANY Q10) Here I am betting on future pontential and income like we should all do. This not a new company. Been around on market for long time now. Like I said, it is just a matter of time (CHART LOOK GOOD AND OTHER GOODS NEWS COMING FROM THIS CO). If it was that worst no one in CEO will buyback on regular basis shares on open market. They are negociating with a big energy enterprise to finance an interesting project of gas ( read previous PR from CO).
posted
check IESV,I have fillped this once,it should go in 2-3 mos.May see nice gain after Dec.21 they will have bond money by then.
Posts: 280 | From: w.sacto.ca. u.s.a. | Registered: Feb 2004
| IP: Logged |
posted
CORPUS CHRISTI, Texas, Dec. 14, 2005 (PRIMEZONE) -- CSMG Technologies, Inc. (OTCBB:CTUM) announced today that over 5,000 successful surgeries have now been performed using patented tissue bonding/welding technology licensed by the company. The surgeries have been performed by doctors in the Ukraine in nearly 70 different approved surgical procedures.
Use of the tissue welding technology in Ukraine is successfully growing as the medical facility continues to develop new, unique methods of post-traumatic recovery and preservation of vitality in organs that previously were believed to be inoperable.
Don Robbins, CEO of CSMG Technologies, said, "This is important further evidence of the validity of the tissue bonding/welding technology that we have licensed. Our patented bonding/welding procedures are almost bloodless and completed in less time than conventional surgeries. We are very happy with the progress we are making and the enormous benefit we have brought to our patients. We believe this radio frequency fusion technology, which does not use staples, sutures, glues or sealant, will lead to a new age for surgical procedures and faster healing of soft biological tissues."
About CTUM's Tissue Bonding Technology
CTUM's patented tissue welding/bonding device bonds through radio frequency fusion and reconnects living soft biological tissue (organs) without the use of foreign matter or conventional wound-closing devices such as sutures, staples, sealant or glues. The technology leaves little or no scar visible to the naked eye after a few months. Unlike other tissue coagulation methods that tend to destroy tissue by charring, searing and necrosis, the CTUM-patented technology bonds and reconnects incised tissue and avoids this by using a patented low-heat delivery method aimed at restoration of the normal functions of the live organs and tissue. U.S. and Australia patents have been issued with other U.S. and foreign patents pending.
In Ukraine, more than 5,000 successful human surgeries in clinical trials have been completed on various organs using a number of types of procedures. Surgeons at four Ukraine hospitals and clinics are using the tissue bonding technology in clinical trials and are performing open and laparoscopic surgical procedures.
CTUM owns the technology and exclusive world rights to the medical device through Live Tissue Connect, Inc., a subsidiary corporation formed for the development and exploitation of the platform technology. The technology, owned by CTUM, was invented and developed at the internationally renowned E.O. Paton Institute of Electric Welding, National Academy of Sciences of Ukraine at Kiev, Ukraine, headed by Professor B.E. Paton.
CTUM maintains offices in Corpus Christi, Texas, Washington D.C., Atlanta, Ga., and Kiev, Ukraine.
Additional information about CSMG can be found at http://www.ctum.com or e-mail publicrelations*ctum.com. An online investor kit containing CSMG press releases, SEC filings, current Level II price quotes, interactive Java, stock charts and other useful information for investors can be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com.
Investors may contact Don Robbins or K. Bruce Jones, CSMG, at (361) 887-7546, e-mail: publicrelations*ctum.com, or Frank Hawkins or Julie Marshall, Hawk Associates, at (305) 451-1888, e-mail: info*hawkassociates.com.
Safe-Harbor Statement: Under the Private Securities Litigation Reform Act of 1995. This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors.
CONTACT: CSMG Technologies, Inc. Donald S. Robbins, President and CEO (361) 887-7546
-------------------- ......in Psychiatry circles it's known as a "warning sign" Posts: 1736 | From: Saint Louis | Registered: Jul 2005
| IP: Logged |
posted
i just got me a whole 4000 shares but if it makes it to .08 its a whole $120 better then nothing but thats all the money i had in my account to buy with
-------------------- Derek S Posts: 2270 | From: andalusia, IL, USA | Registered: May 2004
| IP: Logged |
posted
Forrestgump: you say,not enouhg buyers,you are right. Why,you had news,some think good,I say just news. It moved all of .008,I don't call that good news. Also it took about 3 times the vol. to do it. If this moves to .20 by 6-1-06 you will be lucky. I hope I am wrong,but thats how I see it.
Posts: 280 | From: w.sacto.ca. u.s.a. | Registered: Feb 2004
| IP: Logged |
Look at the chart. Candlestick about to move over MM30 day. Float only 15 millions. Good news. Very tought to get shares. CTUM should be at least at30 cents by now but lack of exposure. Are you in or out slim? Anyway chart look VERY GOOD. You have to be patient. May gap tomorrow, who know?
posted
...Just try to buy 100k shares in one shot...good luck. So what your point? If you don't like this stock, fine with me, but I personnaly believe soon or later CTUM will run...
Posts: 1335 | Registered: Oct 2003
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Eek!]](eek.gif)
